Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S, Bellera C, Dabakuyo-Yonli TS. Gourgou-Bourgade S, et al. Among authors: van der hage ja, van tienhoven g. Ann Oncol. 2015 May;26(5):873-879. doi: 10.1093/annonc/mdv106. Epub 2015 Feb 27. Ann Oncol. 2015. PMID: 25725046 Free article. Review.
Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology).
Bartelink H, Garavaglia G, Johansson KA, Mijnheer BJ, Van den Bogaert W, van Tienhoven G, Yarnold J. Bartelink H, et al. Among authors: van tienhoven g, van den bogaert w. Radiother Oncol. 1991 Dec;22(4):323-6. doi: 10.1016/0167-8140(91)90172-d. Radiother Oncol. 1991. PMID: 1792330 Review.
EORTC guidelines for writing protocols for clinical trials of radiotherapy.
Bolla M, Bartelink H, Garavaglia G, Gonzalez D, Horiot JC, Johansson KA, van Tienhoven G, Vantongelen K, van Glabbeke M. Bolla M, et al. Among authors: van glabbeke m, van tienhoven g. Radiother Oncol. 1995 Jul;36(1):1-8. doi: 10.1016/0167-8140(95)01573-y. Radiother Oncol. 1995. PMID: 8525020
Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review.
Poortmans P, Kouloulias VE, Venselaar JL, Struikmans H, Davis JB, Huyskens D, van Tienhoven G, Hurkmans C, Mijnheer B, Van den Bogaert W. Poortmans P, et al. Among authors: van tienhoven g, van den bogaert w. Eur J Cancer. 2003 Sep;39(14):2035-42. doi: 10.1016/s0959-8049(03)00455-6. Eur J Cancer. 2003. PMID: 12957458
Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period.
Poortmans PM, Ataman F, Davis JB, Bartelink H, Horiot JC, Pierart M, Collette L, Van Tienhoven G. Poortmans PM, et al. Among authors: van tienhoven g. Radiother Oncol. 2005 Sep;76(3):278-84. doi: 10.1016/j.radonc.2005.04.001. Radiother Oncol. 2005. PMID: 15919127
Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works.
Poortmans P, Kouloulias V, van Tienhoven G, Collette L, Struikmans H, Venselaar JL, Van den Bogaert W, Davis JB, Lambin P; EORTC Radiation Oncology and Breast Cancer Groups. Poortmans P, et al. Among authors: van tienhoven g, van den bogaert w. Strahlenther Onkol. 2006 Oct;182(10):576-82. doi: 10.1007/s00066-006-1629-2. Strahlenther Onkol. 2006. PMID: 17013570 Clinical Trial.
Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?
Russell NS, Kunkler IH, van Tienhoven G, Canney PA, Thomas J, Bartlett J, van de Vijver MJ, Belkacemi Y, Yarnold JR, Barrett-Lee PJ. Russell NS, et al. Among authors: van tienhoven g, van de vijver mj. J Clin Oncol. 2009 Feb 20;27(6):996-7; author reply 997-8. doi: 10.1200/JCO.2008.18.7062. Epub 2009 Jan 21. J Clin Oncol. 2009. PMID: 19164209 No abstract available.
Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer.
Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Demonty G, Duez N, Cataliotti L, Klinkenbijl J, Westenberg HA, van der Mijle H, Hurkmans C, Rutgers EJ. Straver ME, et al. Among authors: van tienhoven g, van der mijle h, van de velde cj. J Clin Oncol. 2010 Feb 10;28(5):731-7. doi: 10.1200/JCO.2008.21.7554. Epub 2009 Dec 28. J Clin Oncol. 2010. PMID: 20038733 Free PMC article. Clinical Trial.
Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial.
Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Duez N, Cataliotti L, Klinkenbijl JH, Westenberg HA, van der Mijle H, Snoj M, Hurkmans C, Rutgers EJ. Straver ME, et al. Among authors: van tienhoven g, van der mijle h, van de velde cj. Ann Surg Oncol. 2010 Jul;17(7):1854-61. doi: 10.1245/s10434-010-0945-z. Epub 2010 Mar 19. Ann Surg Oncol. 2010. PMID: 20300966 Free PMC article. Clinical Trial.
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
Van Laethem JL, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, Peeters M, Polus M, Praet M, Mauer M, Collette L, Budach V, Lutz M, Van Cutsem E, Haustermans K. Van Laethem JL, et al. Among authors: van cutsem e, van tienhoven g. J Clin Oncol. 2010 Oct 10;28(29):4450-6. doi: 10.1200/JCO.2010.30.3446. Epub 2010 Sep 13. J Clin Oncol. 2010. PMID: 20837948 Free PMC article. Clinical Trial.
195 results